Agios Pharma CFO Jonathan Biller resigns effective Sept 16

AGIOS PHARMACEUTICALS, INC.

Jonathan Biller notified resignation as CFO, head of corporate affairs, effective Sept 16, 2022.
Resignation is to pursue other opportunities; no successor named as of filing date.
Biller served as principal financial officer; departure creates CFO vacancy.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jonathan Biller

Chief Financial Officer

AGIO · AGIOS PHARMACEUTICALS, INC.

Effective: 2022-09-16
Filed: September 7, 2022, 7:59 PM ET

On September 6, 2022, Jonathan Biller notified the Company of his intention to resign as chief financial officer, head of corporate affairs and principal financial officer of the Company, effective September 16, 2022, in order to pursue other opportunities.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jonathan Biller resigned as Chief Financial Officer at AGIOS PHARMACEUTICALS, INC..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On September 6, 2022, Jonathan Biller notified the Company of his intention to resign as chief financial officer, head of corporate affairs and principal financial officer of the Company, effective September 16, 2022, in order to pursue other opportunities.

View on SEC.gov

AGIOS PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-22-239454

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.